Determine the necessary mass, volume, or concentration for preparing a solution.
10mM in DMSO for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
SBI-581 is an orally active and potent selective serine-threonine kinase TAO3 inhibitor, with an IC 50 of 42 nM. SBI-581 promotes TKS5α accumulation at RAB11-positive vesicles. SBI-581 inhibits invadopodia formation. SBI-581 shows reasonable pharmacokinet
IC50& Target:IC 50 : 42 nM (TAO3), 237 nM (MEKK3)
In Vitro:SBI-581 shows moderate selectivity (> 5-10x) against the majority of a broad panel of kinases. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo:SBI-581 (10mg/kg, IP, once) displays reasonable pharmacokinetics (t 1/2 =1.5 hr; AUC= 1202 hr*ng/mL; Cmax= ~2 μM). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Biological Activity:SBI-581 is an orally active and potent selective serine-threonine kinase TAO3 inhibitor, with an IC 50 of 42 nM. SBI-581 promotes TKS5α accumulation at RAB11-positive vesicles. SBI-581 inhibits invadopodia formation. SBI-581 shows reasonable pharmacokinet
| Canonical Smiles | O=C1/C(C2=C(C=CC=C2C#CC3(O)CCNCC3)N1)=C\\C4=CC5=C(N4)C=CC=C5 |
|---|---|
| Molecular Weight | 383.44 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →